Colleen Brophy
-
Research Snapshot: New drug targets vascular inflammation, drastically improving the long-term effectiveness of vascular procedures
Therapeutic MK2i-NP blocks both inflammation and an unhealthy conversion of cells in blood vessels after cardiovascular procedures, reducing the need for further interventions—cutting costs and reducing risks. Est. reading time: 2.5 minutes. Read MoreOct 11, 2021
-
New nanoparticle enhances success rate of coronary artery bypass grafts
A team of Vanderbilt University Medical Center surgeons and biomedical engineers has developed a nanoparticle delivery system that may significantly improve the success rate of coronary artery bypass grafts. Read MoreJun 18, 2015
-
‘Glass ceiling’ exists for women surgeons
Less than a third of surgeons who advance to senior ranks in the U.S. are women, and it's not because they're less qualified or less productive than their male counterparts, new research finds. Read MoreFeb 21, 2011